- Home
- OKYO vs PBHC Comparison
OKYO vs PBHC Comparison
Compare OKYO & PBHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- PBHC
- Stock Information
- Founded
- OKYO 2007
- PBHC 1859
- Country
- OKYO United Kingdom
- PBHC United States
- Employees
- OKYO N/A
- PBHC N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- PBHC Major Banks
- Sector
- OKYO Health Care
- PBHC Finance
- Exchange
- OKYO Nasdaq
- PBHC Nasdaq
- Market Cap
- OKYO 79.7M
- PBHC 92.9M
- IPO Year
- OKYO 2022
- PBHC N/A
- Fundamental
- Price
- OKYO $1.99
- PBHC $14.43
- Analyst Decision
- OKYO Strong Buy
- PBHC
- Analyst Count
- OKYO 1
- PBHC 0
- Target Price
- OKYO $7.00
- PBHC N/A
- AVG Volume (30 Days)
- OKYO 118.6K
- PBHC 3.2K
- Earning Date
- OKYO 07-18-2025
- PBHC 10-30-2025
- Dividend Yield
- OKYO N/A
- PBHC 2.89%
- EPS Growth
- OKYO N/A
- PBHC N/A
- EPS
- OKYO N/A
- PBHC 1.07
- Revenue
- OKYO N/A
- PBHC $44,154,000.00
- Revenue This Year
- OKYO N/A
- PBHC N/A
- Revenue Next Year
- OKYO N/A
- PBHC N/A
- P/E Ratio
- OKYO N/A
- PBHC $12.87
- Revenue Growth
- OKYO N/A
- PBHC 24.40
- 52 Week Low
- OKYO $0.90
- PBHC $13.55
- 52 Week High
- OKYO $3.35
- PBHC $18.53
- Technical
- Relative Strength Index (RSI)
- OKYO 39.72
- PBHC 30.75
- Support Level
- OKYO $1.90
- PBHC $14.82
- Resistance Level
- OKYO $2.54
- PBHC $14.81
- Average True Range (ATR)
- OKYO 0.25
- PBHC 0.28
- MACD
- OKYO -0.06
- PBHC -0.11
- Stochastic Oscillator
- OKYO 6.83
- PBHC 17.14
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About PBHC Pathfinder Bancorp Inc. (MD)
Pathfinder Bancorp Inc is a holding company for Pathfinder Bank. The Pathfinder Bank is a commercial bank engaged in attracting deposits from the general public and investing such deposits, together with other sources of funds, in loans secured by residential real estate, commercial real estate, small business loans, and consumer loans. The bank invests a portion of its assets in debt securities issued by the United States Government and its agencies and sponsored enterprises, state and municipal obligations, corporate debt securities, mutual funds, and equity securities. The principal source of income is interest on loans and investment securities.